Hepatic Oncology

期刊简介：Primary liver cancer is the sixth most common cancer in the world, and the third most common cause of death from malignant disease. Traditionally more common in developing countries, hepatocellular carcinoma is becoming increasingly prevalent in the Western world, primarily due to an increase in hepatitis C virus infection. Emerging risk factors, such as non-alcoholic fatty liver disease and obesity are also of concern for the future. In addition, metastatic tumors of the liver are more common than primary disease. Some studies report hepatic metastases in as many as 40 to 50% of adult patients with extrahepatic primary tumors. Hepatic Oncology publishes original research studies and reviews addressing preventive, diagnostic and therapeutic approaches to all types of cancer of the liver, in both the adult and pediatric populations. The journal also highlights significant advances in basic and translational research, and places them in context for future therapy. Hepatic Oncology provides a forum to report and debate all aspects of cancer of the liver and bile ducts. The journal publishes original research studies, full reviews and commentaries, with all articles subject to independent review by a minimum of three independent experts. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3. Coverage includes: Studies on all types of primary and secondary hepatic cancers, including hepatocellular carcinoma, cholangiocarcinoma, hepatoblastoma, fibrolamellar carcinoma and mesenchymal cancers of the liver Clinical trials in hepatic oncology Diagnosis and imaging Epidemiology Palliative care Pathogenesis Pathology Pediatrics Pharmacoeconomics, outcomes and comparative effectiveness research Prognosis Risk factors Staging Surveillance Therapy, including surgery, chemotherapy, chemoembolization, ablation, radiotherapy, hormonal and biological therapies Translational research and biomarker studies

【译文】原发性肝癌是世界上第六大常见癌症，也是恶性肿瘤死亡的第三大常见原因。传统上，肝细胞癌在发展中国家更为常见，但在西方世界也变得越来越普遍，这主要是由于丙型肝炎病毒感染的增加。非酒精性脂肪肝和肥胖等新出现的危险因素也值得未来关注。此外，肝脏转移性肿瘤比原发性疾病更常见。一些研究报告称，多达 40% 至 50% 的肝外原发性肿瘤成年患者出现肝转移。 《肝肿瘤学》发表原创研究和评论，涉及成人和儿童人群中所有类型肝癌的预防、诊断和治疗方法。该杂志还强调了基础研究和转化研究的重大进展，并将其置于未来治疗的背景下。肝脏肿瘤学提供了一个报告和辩论肝癌和胆管癌各个方面的论坛。该杂志发表原创研究、完整评论和评论，所有文章均须接受至少三名独立专家的独立审查。欢迎主动提出文章提案，作者必须完全遵守期刊的披露和利益冲突政策以及主要出版指南，包括 ICMJE 和 GPP3。覆盖范围包括： 所有类型的原发性和继发性肝癌的研究，包括肝细胞癌、胆管癌、肝母细胞瘤、纤维板层癌和间叶性肝癌的研究 肝肿瘤学的临床试验 诊断和影像学 流行病学 姑息治疗 发病机制 病理学 儿科 药物经济学、结果和比较有效性研究 预后 危险因素 分期监测 治疗，包括手术、化疗、化疗栓塞、消融、放射治疗、激素和生物疗法转化研究和生物标志物研究